Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis

AIM: To investigate whether an elevated preoperative neutrophil-to-lymphocyte ratio(NLR) can predict poor survival in patients with hepatocellular carcinoma(HCC).METHODS: We retrospectively reviewed 526 patients with HCC who underwent surgery between 2004 and 2011.RESULTS: Preoperative NLR ≥ 2.81 wa...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 22; no. 21; pp. 5088 - 5095
Main Authors Yang, Hao-Jie, Guo, Zhe, Yang, Yu-Ting, Jiang, Jing-Hang, Qi, Ya-Peng, Li, Ji-Jia, Li, Le-Qun, Xiang, Bang-De
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Inc 07.06.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AIM: To investigate whether an elevated preoperative neutrophil-to-lymphocyte ratio(NLR) can predict poor survival in patients with hepatocellular carcinoma(HCC).METHODS: We retrospectively reviewed 526 patients with HCC who underwent surgery between 2004 and 2011.RESULTS: Preoperative NLR ≥ 2.81 was an independent predictor of poor disease-free survival(DFS, P < 0.001) and overall survival(OS, P = 0.044). Compared with patients who showed a preoperative NLR < 2.81 and postoperative increase, patients who showed preoperative NLR ≥ 2.81 and postoperative decrease had worse survival(DFS, P < 0.001; OS, P < 0.001). Among patients with preoperative NLR ≥ 2.81, survival was significantly higher among those showing a postoperative decrease in NLR than among those showing an increase(DFS, P < 0.001; OS, P < 0.001). When elevated, alpha-fetoprotein(AFP) provided no prognostic information, and so preoperative NLR ≥ 2.81 may be a good complementary indicator of poor OS whenever AFP levels are low or high.CONCLUSION: Preoperative NLR ≥ 2.81 may be an indicator of poor DFS and OS in patients with HCC undergoing surgery. Preoperative NLR ≥ 2.81 may be a good complementary indicator of poor OS when elevated AFP levels provide no prognostic information.
Bibliography:Hao-Jie Yang;Zhe Guo;Yu-Ting Yang;Jing-Hang Jiang;Ya-Peng Qi;Ji-Jia Li;Le-Qun Li;Bang-De Xiang;Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University;Department of General Surgery, the First People’s Hospital of Changde;Department of Thyroid and Breast Surgery, Central Hospital of Wuhan;Department of Oncology, the First People’s Hospital of Changde;Department of General Surgery, Second People’s Hospital of Jingmen;Guangxi Medical University
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: Yang HJ, Guo Z and Yang YT contributed equally to this work; Xiang BD and Li LQ designed the research; Yang HJ, Guo Z, Yang YT and Qi YP performed the research; Yang HJ, Yang YT and Li JJ evaluated the clinic records and performed the statistical analyses; Yang HJ wrote the manuscript; all authors read and approved the final manuscript.
Correspondence to: Bang-De Xiang, Professor, Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, 71 Hedi Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. yhj894924067@163.com
Telephone: +86-771-5310045 Fax: +86-771-5312000
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v22.i21.5088